STOCK TITAN

Warby Parker Insider Sales: 316,640 Shares Sold Recently; 175,000-Share Sale Planned

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Warby Parker Inc. (WRBY) filing a Form 144 notifies a proposed sale of 175,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $4,681,250 and an approximate sale date of 09/18/2025 on the NYSE. The securities were acquired on 06/28/2017 via previously exercised stock options and paid in cash. The filing also discloses prior sales by related parties and 10b5-1 plans totaling 316,640 shares sold in the past three months for gross proceeds of about $8.09 million, showing ongoing insider disposition activity.

Positive

  • Full disclosure of proposed sale details including broker, share count, and aggregate market value
  • Use of 10b5-1 plans is documented, indicating preplanned, rule-compliant sales
  • Acquisition details provided (exercise of stock options on 06/28/2017, paid in cash), clarifying basis

Negative

  • Significant insider selling in past three months: 316,640 shares sold for approximately $8.09 million
  • Additional planned sale of 175,000 shares valued at $4,681,250 may further increase share supply

Insights

TL;DR: Significant insider share dispositions totaling ~316,640 shares recently and a planned 175,000-share sale may increase share supply.

The filing documents a planned sale of 175,000 shares valued at $4.68 million, plus detailed recent dispositions across multiple dates and sellers that generated roughly $8.09 million in gross proceeds. The shares proposed for sale were acquired by exercise of options in 2017 and paid in cash, indicating these are long-held positions becoming liquid. The presence of multiple 10b5-1 plan sales in the history indicates the transactions may be structured and preplanned rather than opportunistic market timing.

TL;DR: The filing shows transparent disclosure and reliance on 10b5-1 plans, but material insider selling is notable.

The Form 144 provides clear broker, amount, and acquisition details required for Rule 144 compliance. Multiple sellers and recurring 10b5-1 sales are documented, which supports procedural compliance and disclosure best practices. From a governance perspective, the volume and frequency of disposals disclosed are material to stakeholders assessing insider alignment, though the filing itself contains no nonpublic operational information and includes the signer’s representation of no undisclosed material adverse facts.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does the WRBY Form 144 propose to sell?

The notice proposes sale of 175,000 common shares through Morgan Stanley Smith Barney with aggregate market value of $4,681,250 and an approximate sale date of 09/18/2025.

When and how were the proposed shares acquired?

The shares were acquired on 06/28/2017 through previously exercised stock options and payment was made in cash on that date.

How much insider selling occurred in the past three months according to the filing?

The filing lists sales totaling 316,640 shares across multiple sellers/dates, generating approximately $8.09 million in gross proceeds.

Are any of the sales part of 10b5-1 plans?

Yes. The filing identifies multiple 10b5-1 sales attributed to David Gilboa and other parties, indicating planned trading arrangements.

Which broker is handling the proposed sale?

The proposed sale is to be handled by Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York, NY.
Warby Parker Inc

NYSE:WRBY

WRBY Rankings

WRBY Latest News

WRBY Latest SEC Filings

WRBY Stock Data

3.22B
97.87M
7.51%
95.76%
7.49%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
NEW YORK